ADMA Biologics heads into earnings with shorts rebuilding into the print
ADMA Biologics reports Thursday with a familiar tension: a stock that has rallied 11.5% over the past month is now pulling back into the number, down 6% on the week to $10.25, while short interest has quietly rebuilt…
